Author = Jiaxiang Ye
Number of Articles: 4
1. lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma

Volume 22, Issue 12, December 2021, Pages 3741-3753

Siyao Wu; Yayan Deng; Yue Luo; Jiaxiang Ye; Zhihui Liu


2. Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis

Volume 21, Issue 6, June 2020, Pages 1787-1795

Jiaxiang Ye; Haixia Li; Jiazhang Wei; Yue Luo; Hongmei Liu; Jinyan Zhang; Xiaoling Luo


3. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis

Volume 19, Issue 5, May 2018, Pages 1397-1404

Zhong Guo Liang; Guo Xiang Lin; Jia Xiang Ye; Ye Li; Ling Li; Song Qu; Xia Liang; Xiao Dong Zhu


4. Compliance with National Guidelines on the Treatment of Stage II–IVB Nasopharyngeal Carcinoma in a Regional Cancer Center of Southern China

Volume 19, Issue 1, January 2018, Pages 115-120

Jia-xiang Ye; Xia Liang; Jian Wei; Jing Zhou; Yu Liao; Yu-Lei Lu; Xia-Quan Tang; An-Yu Wang; Yong Tang